EN DE

Shiseido Company (SSDOY) Fair Value & Analysis

Consumer Defensive · US · Market cap $6.2B

SC Shiseido Company logo Shiseido Company SSDOY · US
Price$23.16
Fair Value$3.43
Upside-85.2%
Quality54/100
Watch Shiseido Company for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -3.7% net margin
Low debt · generates free cash flow
1.68% dividend yield
Trails peers (3/12)
Narrow moat 24/100
Evidence: High Range $2.23 – $4.64 Share as image

Fair value as of: Jul 19, 2026

From 13 valuation models · updated 22 days ago

Fair value updated Jul 19, 2026, revised from $15.34 to $3.43 (−77.6%) since Jun 24, 2026. Share price +34.7% over the past month.

A solid business, but screening 85% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case ($4.64). The favourable scenario is already priced in.
  • Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
  • A fairly wide model range ($2.23 to $4.64) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$69.10 $13.43 Fair Value $3.43 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 19, 2026.

How to read this chart

60‑month range $13.43 – $69.10 · fair‑value band $2.23 – $4.64 · the $23.16 price screens above the $3.43 fair value. Dashed = 300-day average. As of Jul 19, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Shiseido Company (SSDOY) currently trades at $23.16, while our model-based Fair Value estimate is $3.43, implying the stock looks roughly 85.2% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Shiseido Company generated revenue of $974B at a net margin of -3.7%. Revenue grew 1.6% year over year. It earns a return on equity of -5.6%. Net debt stands at $231B. Fundamentals as of Jul 19, 2026

Our scenario range runs from $2.23 (bear case) to $4.64 (bull case); at $23.16, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 73% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at -85%, SSDOY screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF $9.35 $12.88 $18.11 80
Rev-Margin DCF $4.09 $5.65 $7.53 74
ROIC Compounder $0.1015 $0.2772 72
All 13 models by family
DCF Models
FCF DCF $9.02 $12.72 $18.54 38
5Y Revenue Exit $4.09 $5.43 $7.15 39
5Y EBITDA Exit $10.15 $15.88 $22.79 41
10Y Revenue Exit $5.88 $7.36 $8.93 36
10Y EBITDA Exit $9.61 $14.15 $19.43 37
Earnings-Based
EPV $0.1015 $0.2772 59
Multiples
EV/EBIT $2.22 $3.43 $4.64 53
EV/EBITDA $12.74 $17.46 $22.17 54
EV/Revenue $1.19 $2.30 $3.40 43
Asset-Based
NCAV (Graham) $4.66 $6.24 $9.32 50
Growth DCF
Growth DCF $9.35 $12.88 $18.11 80
Rev-Margin DCF $4.09 $5.65 $7.53 74
Economic Profit
ROIC Compounder $0.1015 $0.2772 72

Widest divergence: DCF Models ($12.72) versus Earnings-Based ($0.1015). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) $974B
Revenue growth (YoY) +1.6%
Net margin -3.7%
Return on equity -5.6%
Free cash flow $68.6B FY2025
Operating margin 5.3%
More key figures
EPS (TTM) $-0.6300
Dividend yield 1.7%
EPS growth (YoY) +127%
Net debt $231B FY2025

Figures from reported company fundamentals · as of Jul 19, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 54/100

Of which business quality 52 · Market factors (momentum, volatility) 72

Profitability 33
Margins and returns on capital today
Quality Growth 49
Are margins and returns improving?
Cashflow 42
Earnings quality: real cash, not paper profit
Fin. Strength 41
Balance sheet, leverage, solvency risk
Investment 95
Disciplined investing over empire-building
Low Volatility 65
Calm price path (market factor)
Momentum 64
Price trend over the last 3–12 months (market factor)
52W Momentum 92
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Shiseido Company, Limited produces and sells in Japan and internationally. It offers fragrances, skincare, and makeup products through retail channels. The company also engages in the restaurant and food businesses; and operates beauty salons. In addition, it operates and supports SABFA, a professional hair makeup training school.

Full company description

Shiseido Company, Limited produces and sells in Japan and internationally. It offers fragrances, skincare, and makeup products through retail channels. The company also engages in the restaurant and food businesses; and operates beauty salons. In addition, it operates and supports SABFA, a professional hair makeup training school. Further, the company manages childcare facilities. It serves its products under the BAUM, BENEFIQUE, Clé de Peau Beauté, Dr. Dennis Gross Skincare, Drunk Elephant, EFFECTIM, Gallinée, INOUI, IPSA, ISSEY MIYAKE PARFUMS, NARS, narciso rodriguez, Serge Lutens, SHISEIDO, THE GINZA, Tory Burch Beauty, ZADIG&VOLTAIRE, ANESSA, AQUA LABEL, AUPRES, d program, ELIXIR, HAKU, INTEGRATE, MAJOLICA MAJORCA, MAQuillAGE, PRIOR, REVITAL, URARA, INRYU, The Collagen, and Perfect Cover brands. The company sells its products through department, specialized cosmetic, drug, and general merchandise stores. Shiseido Company, Limited was founded in 1872 and is headquartered in Chuo, Japan.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Shiseido Company reported revenue of $1.0T in FY2025 versus $1.0T in FY2021, a compound −0.4%/yr. Reported net income was −$42.7B in FY2025.

Growth Quality 34/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$1.0T
Latest YoY
+2.7%
Avg. growth/yr (3Y)
−1.6%
Avg. growth/yr (5Y)
+2.0%
Avg. growth/yr (30Y)
+2.0%
Revenue −0.4%/yr
FY21 $1.0T
FY22 $1.1T
FY23 $973B
FY24 $991B
FY25 $1.0T
Net income
FY21 $46.9B
FY22 $34.2B
FY23 $21.7B
FY24 −$10.8B
FY25 −$42.7B

SSDOY screens 85% overvalued. Compare with The Procter & Gamble Company →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Shiseido Company Fair Value". https://www.fairvalue-calculator.com/stock/SSDOY

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Household & Personal Products · 244 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 54 · Below median
Fair Value upside −85% · Bottom 25%
Return on assets 1% · Below median
Net margin (TTM) -4% · Bottom 25%
Operating margin (TTM) 5% · Below median
Revenue growth 2% · Above median
Dividend yield (TTM) 1.7% · Below median
Debt / equity 0.30× · Higher than median

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/FCF 0.1× · Cheaper than 75% of peers
EV/EBITDA 1.2× · Cheaper than 75% of peers
PEG 2.18× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 28
FUTURE 8 · sector 4
PAST 0 · sector 26
HEALTH 85 · sector 98
DIVIDEND 34 · sector 50

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $146.80 $108.16 -26%
Unilever PLC ULN 1,080 MXN 1,273 MXN +18%
Hindustan Unilever Limited HINDUNILVR ₹2,144 ₹1,000 -53%
Essity AB ESSITYA kr 279.00 kr 250.02 -10%
Godrej Consumer Products Limited GODREJCP ₹1,088 ₹367.64 -66%
Marico Limited MARICO ₹846.75 ₹233.05 -72%
APR Co 278470 375,000 KRW 151,222 KRW -60%
Dabur India Limited DABUR ₹429.45 ₹181.60 -58%
Kimberly-Clark de México, S. A. B. de C. V., KIMBERA 38.07 MXN 50.09 MXN +32%
PT Unilever Indonesia Tbk UNVR 1,730 IDR 1,934 IDR +12%

Compare Shiseido Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Shiseido Company (SSDOY) overvalued or undervalued?
As of Jul 19, 2026, our model estimates a fair value of $3.43 versus a price of $23.16, about −85% (overvalued).
What is the fair value of SSDOY?
Our model-based fair value for Shiseido Company is $3.43 (as of Jul 19, 2026), built from audited fundamentals. The current price is $23.16.
What is the quality score of SSDOY?
Shiseido Company has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Shiseido Company (SSDOY)?
Shiseido Company reported trailing-twelve-month revenue of about $974B (latest available figure, as of Jul 19, 2026).
What is the net profit margin of SSDOY?
The net profit margin of Shiseido Company is about -3.7%, meaning it is currently running at a net loss. Based on the latest reported figures.
Does Shiseido Company pay a dividend?
Shiseido Company currently shows a dividend yield of about 1.68% relative to its recent price (as of Jul 19, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Shiseido Company and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.